INNOGENE Co.,Ltd. (KOSDAQ:344860)

INNOGENE Revenue

INNOGENE had revenue of 4.80B KRW in the quarter ending June 30, 2026, with 153.13% growth. This brings the company's total for the last twelve months to 11.94B, up 56.46% year-over-year. In the year 2025, INNOGENE had annual revenue of 8.21B, down -8.17%. That makes INNOGENE the 37,797th largest company in the world by revenue and 2,403rd in South Korea.

• Revenue (ttm): 11.94B
• Revenue Growth: +56.46%
• P/S Ratio: 1.78
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 21.30B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

• Cosmetics and Medical Devices Product 7.57B 84.6%
• Cosmetics and Medical Devices Commodity 1.38B 15.4%

By Geography

• South Korea 7.61B 85.0%
• Overseas 1.34B 15.0%

Fiscal year ended Dec 31, 2024 See the full INNOGENE breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.21B	-731.15M	-8.17%
Dec 31, 2024	8.94B	-1.16B	-11.45%
Dec 31, 2023	10.10B	961.65M	10.52%
Dec 31, 2022	9.14B	-245.63M	-2.62%
Dec 31, 2021	9.39B	3.74B	66.29%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error